Cellular and Molecular Neurobiology

, Volume 30, Issue 3, pp 389–394 | Cite as

Alpha-Tocopherol Decreases Iron-Induced Hippocampal and Nigral Neuron Loss

  • M. Ömer BostanciEmail author
  • Orhan Bas
  • Faruk Bagirici
Original Research


There are many studies about iron-induced neuronal hyperactivity and oxidative stress. Some reports also showed that iron levels rise in the brain in some neurodegenerative diseases such as Parkinson’s (PD) and Alzheimer’s disease (AD). It has been suggested that excessive iron level increases oxidative stress and causes neuronal death. Tocopherols act as a free radical scavenger when phenoxylic head group encounters a free radical. We have aimed to identify the effect of α-tocopherol (Vitamin E) on iron-induced neurotoxicity. For this reason, rats were divided into three groups as control, iron, and iron + α-tocopherol groups. Iron chloride (200 mM in 2.5 μl volume) was injected into brain ventricle of iron and iron + α-tocopherol group rats. Same volume of saline (2.5 μl) was given to the rats belonging to control group. Rats of iron + α-tocopherol group received intraperitoneally (i.p.) α-tocopherol (100 mg/kg/day) for 10 days. After 10 days, rats were perfused intracardially under deep urethane anesthesia. Removed brains were processed using standard histological techniques. The numbers of neurons in hippocampus and substantia nigra of all rats were estimated by stereological techniques. Results of present study show that α-tocopherol decreased hippocampal and nigral neuron loss from 51.7 to 12.1% and 41.6 to 17.8%, respectively. Findings of the present study suggest that α-tocopherol may have neuroprotective effects against iron-induced hippocampal and nigral neurotoxicity and it may have a therapeutic significance for neurodegenerative diseases involved iron.


Iron Hippocampus Substantia nigra Cell death Alpha-tocopherol Stereology 



This study was supported by The Research Fund of Ondokuz Mayis University.


  1. Amoroso S, Gioielli A, Cataldi M, Di Renzo G, Annunziato L (1999) In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca2+ increase. Biochim Biophys Acta 1452:151–160CrossRefPubMedGoogle Scholar
  2. Behl C, Davis J, Cole GM, Schubert D (1992) Vitamin E protects nerve cells from amyloid h protein toxicity. Biochem Biophys Res Commun 186:944–950CrossRefPubMedGoogle Scholar
  3. Bondy SC, Guo S, Adams JD (1996) Prevention of ethanol-induced changes in reactive oxygen parameters by alpha-tocopherol. Alcohol Alcohol 31:403–410PubMedGoogle Scholar
  4. Bostanci MO, Bagirici F (2008) Nitric oxide synthesis inhibition attenuates iron-induced neurotoxicity: a stereological study. Neurotoxicology 29(1):130–135CrossRefPubMedGoogle Scholar
  5. Bostanci MO, Bagirici F, Canan S (2006) A calcium channel blocker flunarizine attenuates the neurotoxic effects of iron. Cell Biol Toxicol 22:119–125CrossRefPubMedGoogle Scholar
  6. Bostanci MO, Bagirici F, Bas O (2008) Role of nitric oxide synthesis inhibitors in iron-induced nigral neurotoxicity: a mechanistic exploration. Toxicol Mech Methods 116:379–384CrossRefGoogle Scholar
  7. Burton GW, Ingold KU (1989) Vitamin E as an in vitro and in vivo antioxidant. Ann NY Acad Sci 570:7–22CrossRefPubMedGoogle Scholar
  8. Burton GW, Ingold KU, Foster DO, Cheng SC, Webb A, Hughes L, Lusztyk E (1988) Comparison of free α-tocopherol and α-tocopherol acetate as sources of vitamin E in rats and humans. Lipids 23:834–840CrossRefPubMedGoogle Scholar
  9. Ciani E, Groneng L, Voltattorni M, Rolseth V, Contestabile A, Paulsen RE (1996) Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons. Brain Res 728:1–6CrossRefPubMedGoogle Scholar
  10. Crouzin N, Ferreira MC, Cohen-Solal C, Aimar RF, Vignes M, Guiramand J (2007) α-Tocopherol-mediated long-lasting protection against oxidative damage involves an attenuation of calcium entry through TRP-like channels in cultured hippocampal neurons. Free Radic Biol Med 42:1326–1337CrossRefPubMedGoogle Scholar
  11. Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress. J Neurol Sci 143:137–142CrossRefPubMedGoogle Scholar
  12. Dexter DT, Carayon A, Agid AF, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953–1975CrossRefPubMedGoogle Scholar
  13. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Wittenman JCM, Breteler MMB (2002) Dietary intake of antioxidant and risk of Alzheimer’s disease. JAMA 287:3223–3229CrossRefPubMedGoogle Scholar
  14. Ferreira MC, Crouzin N, Barbanel G, Cohen-Solal C, Récasens M, Vignes M, Guiramand J (2005) A transient treatment of hippocampal neurons with alpha-tocopherol induces a long-lasting protection against oxidative damage via a genomic action. Free Radic Biol Med 39:1009–1020CrossRefGoogle Scholar
  15. Galbussera A, Tremolizzo L, Brighina L, Testa D, Lovati R, Ferrarese C, Cavaletti G, Filippini G (2006) Vitamin E intake and the quality of life in amyotrophic lateral sclerosis patients: a followup case series study. Neurol Sci 27:190–193CrossRefPubMedGoogle Scholar
  16. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases. J Neurochem 63:793–807PubMedCrossRefGoogle Scholar
  17. Goodman Y, Mattson MP (1994) Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128:1–12CrossRefPubMedGoogle Scholar
  18. Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph AC, Becker G, Osterhage J, Jost WH, Schrank B, Stein C, Kostopulos P, Lubik S, Wekwerth K, Dengler R, Troeger M, Wuerz A, Hoge A, Schrader C, Schimke N, Krampfl K, Petri S, Zierz S, Eger K, Neudecker S, Traufeller K, Sievert M, Neundorfer B, Hecht M (2005) High-dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: a result of placebo controlled double blind study. J Neural Transm 112(5):649–660CrossRefPubMedGoogle Scholar
  19. Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623CrossRefPubMedGoogle Scholar
  20. Halliwell B, Gutteridge JMC (eds) (1989) Free radicals in biology and medicine. Clarendon Press, OxfordGoogle Scholar
  21. Marino MD, Aksenov MY, Kelly SJ (2004) Vitamin E protects against alcohol-induced cell loss and oxidative stress in the neonatal rat hippocampus. Int J Dev Neurosci 22:363–377CrossRefPubMedGoogle Scholar
  22. Mishima K, Tanaka T, Pu F, Egashira N, Iwasaki K, Hidaka R, Matsunaga K, Takata J, Karube Y, Fujiwara M (2003) Vitamin E isoforms alpha-tocotrienol and gamma-tocopherol prevent cerebral infarction in mice. Neurosci Lett 337:56–60CrossRefPubMedGoogle Scholar
  23. Moos T (2002) Brain iron homeostasis. Dan Med Bull 49:279–301PubMedGoogle Scholar
  24. Osakada F, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A (2003) Neuroprotective effects of α-tocopherol on oxidative stress in rat striatal cultures. Eur J Pharmacol 465:15–22CrossRefPubMedGoogle Scholar
  25. Paxinos G, Watson C (1998) The rat brain in the stereotaxic coordinates, 4th edn. Academic Pres, LondonGoogle Scholar
  26. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352:2379–2388CrossRefPubMedGoogle Scholar
  27. Pham DQ, Plakogiannis R (2005) Vitamin E supplementation in Alzheimer’s disease, Parkinson’s disease, tardive dyskinesia, and cataract: Part 2. Ann Pharmacother 39(12):2065–2072CrossRefPubMedGoogle Scholar
  28. Qian ZM, Wang Q (1998) Expression of iron transport proteins and excessive iron accumulation of iron in the brain in neurodegenerative disorders. Brain Res Rev 27:257–267CrossRefPubMedGoogle Scholar
  29. Qian ZM, Wang Q, Pu Y (1997) Brain iron and neurological disorders. Chin Med J 110:455–458PubMedGoogle Scholar
  30. Roghani M, Behzadi G (2001) Neuroprotective effect of vitamin E on the early model of Parkinson’s disease in rat: behavioral and histochemical evidence. Brain Res 892:211–217CrossRefPubMedGoogle Scholar
  31. Sagach VF, Scrosati M, Fielding J, Rossoni G, Galli C, Visioli F (2002) The water-soluble vitamin E analogue Trolox protects against ischemia/reperfusion damage in vitro and ex vivo: a comparison with vitamin E. Pharmacol Res 45:435–439CrossRefPubMedGoogle Scholar
  32. Samudralwer DL, Diprete CC, Ni B-F, Ehmann WD, Markesbery WR (1995) Elemental imbalances in the olfactory pathway in Alzheimer’s disease. J Neurol Sci 130:139–145CrossRefGoogle Scholar
  33. Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130:813–831CrossRefPubMedGoogle Scholar
  34. Schubert D, Kimura H, Maher P (1992) Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA 89:8264–8267CrossRefPubMedGoogle Scholar
  35. Swaiman KF (1991) Hallervorden-Spatz and brain iron metabolism. Arch Neurol 48:1285–1293PubMedGoogle Scholar
  36. Zhang B, Tanaka J, Yang L, Yang L, Sakanaka M, Hata R, Maeda N, Mitsuda N (2004) Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience 126:433–440CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.School of Health, Hitit UniversityCorumTurkey
  2. 2.Department of Anatomy, Faculty of MedicineAfyon Kocatepe UniversityAfyonTurkey
  3. 3.Department of Physiology, Faculty of MedicineOndokuz Mayis UniversitySamsunTurkey

Personalised recommendations